- ATC/DDD Index 2011 (http://www.whocc.no/atc_ddd_index/).
- DANMAP 2009. (www.danmap.org).
- EARSS 2009, European Antimicrobial Resistance Surveillance System (http://www.rivn.nl/earss)
- Engesæter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI. Antibiotic prophylaxis in total hip arthroplasty. Effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22, 170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003; 74 (6): 644-52.
- ESAC 2010, European Surveillance of Antimicrobial Consumption (http://app.esac.ua.ac.be/public/)
- Graziani AL, Lawson LA, Gibson GA, Steiberg MA, MacGregor RR. Vancomycin concentrations in infected and noninfected bone. Antimicrob Agents Chemother 1988; 32 (9): 1320-2.
- Hidron AI, Edwards JR, Horan TC, Sievert DM, Pollock DA, Fridkin SK. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual sum- mary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevetion 2006-2007. Infect Control Hosp Epidemiol 2008; 29 (11): 996-1011.
- Kadudugamuwa JL, Sin LV, Yu J, Francis KP, Purchio TF, Contag PR. Noninvasive optical imaging method to evaluate postantibiotic effects on biofilm infection in vivo. Antimicrob Agents Chemother 2004; 48: 2283-7.
- Leclercq R, Courvalin P. Enterococcus. In: Frontiers in antimicrobial resistance: A tribute to Stuart B. Levy ( eds White DG, Alekshun MN, McDermott P F) 2005: ASM Press, Washington, D.C.
- Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: trends in antibiotic drug use and bacterial resistance, 2001. Critical Care 2010; 14: R113.
- Morris AB, Brown RB, Sands M. Use of rifampin in nonstaphylococcal, nonmycobacterial disease. Antimicrob Agents Chemother 1993; 37: 1-7.
- Pallares R, Pujol M, Pena C, Ariza J, Martin R, Gudiol F. Cephalosporins as a risk factor for nosocomial Enterococcus faecalis bacteremia. Arch Intern Med 1993; 153: 1581-6.
- Rice LB. Emergence of vancomycin-resistant enterococci. Emerg Infect Dis 2001; 2: 183-7.
- Van der Auwera P, Meunier-Carpentier F, Kastersky J. Clinical study of combination therapy with oxacillin and rifampin for staphylococcal infections. Rev Infect Dis (Suppl 3) 1983; 5: S515-S522.
- Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA. Comparative review of the carbapenems. Drug 2007; 67 (7): 1027-52.
Acta Orthopaedica
Volume 84, 2013 - Issue 3